Valbenazine promotes body growth via growth hormone signaling during zebrafish embryonic development (PRJCA016501)
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/DRP014187
下载链接
链接失效反馈官方服务：
资源简介：
Valbenazine (VBZ) is a newly FDA-approved oral VMAT-2 inhibitor and used for the treatment of movement disorders such as tardive dyskinesia (TD), and Tourette syndrome (TS). The main purpose of this project is to study the embryonic developmental toxicity of VBZ
创建时间：
2025-11-18
